Information
- ID of tender
-
8629
- Name of content of tender
-
Zabezpečenie dodávky liekov pre potreby Východoslovenského onkologického ústavu
- Tender ref. no.
-
VOU-2020-07
- Public tender journal ref. no.
-
32089 - MST
- EU journal ref. no.
-
2020/S 172-413871
- Type of tender
-
Nadlimitná zákazka
- Type of public tender
-
Verejná súťaž podľa § 66 (7)
- Type of procurement
-
Goods
- Estimated value
-
8 854 627,5500 EUR
- Main CPV
-
33600000-6 - Pharmaceutical products
- Further CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
33692100-8 - Infusion solutions
60000000-8 - Transport services (excl. Waste transport)
- Tender split into parts
- Yes
- Centralised tender
-
No
- NUTS
-
SK - Slovenská republika
- Brief description of tender or procurement
-
Predmetom zákazky je dodávka liekov pre potreby Východoslovenského onkologického ústavu, a.s.
Predmet zákazky je rozdelený na 61 častí.
Členenie predmetu zákazky na časti a opis požadovaných minimálnych vlastností jednotlivých položiek predmetu zákazky je vzhľadom na značný textový rozsah, uvedený v Prílohe č. 2 súťažných podkladov.
- For evaluation the price is determined
-
including VAT
Schedule
-
Lehota na predkladanie ponúk
-
05.10.2020 13:00:00
-
Planned opening of bids
-
05.10.2020 13:30:00
Documents
|
Name of document
|
Type
|
Size
|
Uploaded on
|
|
|
Profil VO - zverejnené oznámenia zákazky
|
Iný dokument k zákazke
|
?
|
22.06.2021 09:51:34
|
|
|
Profil VO - zverejnené dokumenty zákazky
|
Iný dokument k zákazke
|
?
|
22.06.2021 09:50:25
|
|
|
Zrušenie častí predmetu zákazky v postupe VO - 3
|
Iný dokument k zákazke
|
552.82 KB
|
28.05.2021 14:04:20
|
|
|
Zrušenie častí predmetu zákazky v postupe VO - 2
|
Iný dokument k zákazke
|
877.69 KB
|
23.02.2021 10:21:27
|
|
|
Zrušenie častí predmetu zákazky v postupe VO
|
Iný dokument k zákazke
|
603.53 KB
|
12.11.2020 15:41:46
|
|
|
Súťažné podklady - príloha č. 3 - Návrh zmluvy-v2
|
Súťažné podklady
|
101.5 KB
|
18.09.2020 08:49:14
|
|
|
Súťažné podklady - info-3 - vysvetlenie-3,4,5
|
Súťažné podklady
|
510.45 KB
|
18.09.2020 08:48:02
|
|
|
Súťažné podklady - info-2 - vysvetlenie-2
|
Súťažné podklady
|
498.86 KB
|
14.09.2020 13:15:11
|
|
|
Súťažné podklady - info-1 - vysvetlenie-1
|
Súťažné podklady
|
494.32 KB
|
09.09.2020 11:32:31
|
|
|
Súťažné podklady
|
Súťažné podklady
|
982.55 KB
|
04.09.2020 08:15:07
|
|
|
Súťažné podklady - príloha č. 1 - titulka
|
Súťažné podklady
|
14.11 KB
|
31.08.2020 14:16:01
|
|
|
Súťažné podklady - príloha č. 2 - Opis, cena, krirérium
|
Súťažné podklady
|
71.93 KB
|
31.08.2020 14:16:19
|
|
|
Súťažné podklady - príloha č. 3 - Návrh zmluvy
|
Súťažné podklady
|
102 KB
|
31.08.2020 14:16:37
|
|
|
Súťažné podklady - príloha č. 4 - Subdodávatelia
|
Súťažné podklady
|
15.59 KB
|
31.08.2020 14:16:55
|
|
|
Súťažné podklady - príloha č. 5 - Jednotný európsky dokument
|
Súťažné podklady
|
135.9 KB
|
04.09.2020 08:07:10
|
|
Časť č.1: L01DB01 Doxorubicin
- Status
-
Completed
- Predicted value not including VAT
-
6 605,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.2 : L01CB01 Etoposidum
- Status
-
Completed
- Predicted value not including VAT
-
9 927,1200 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.3: L01DB03 Epirubicin
- Status
-
Completed
- Predicted value not including VAT
-
17 016,1000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.4: L01XA03 Oxaliplatina
- Status
-
Completed
- Predicted value not including VAT
-
23 200,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.5: L01XX17 Topotecan
- Status
-
Completed
- Predicted value not including VAT
-
6 053,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.6: L01BC05 Gemcitabin
- Status
-
Completed
- Predicted value not including VAT
-
26 097,7800 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.7: L01XX19 Irinotecan
- Status
-
Completed
- Predicted value not including VAT
-
47 005,7500 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.8: L01CD02 Docetaxel
- Status
-
Completed
- Predicted value not including VAT
-
21 093,1400 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.9: L01CD01 Paclitaxel
- Status
-
Completed
- Predicted value not including VAT
-
43 712,5600 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.10: L01CA04 Vinorelbin
- Status
-
Completed
- Predicted value not including VAT
-
9 795,8400 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.11: L01DC01 Bleomycin
- Status
-
Completed
- Predicted value not including VAT
-
20 944,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.12: L01DB07 Mitoxantrone
- Status
-
Completed
- Predicted value not including VAT
-
3 084,7500 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.13: A04AA05 Palonosetron
- Status
-
Completed
- Predicted value not including VAT
-
15 800,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.14: L01CA02 Vincristin
- Status
-
Completed
- Predicted value not including VAT
-
5 276,9200 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.15: LV03AF03 Calciumfolinat
- Status
-
Completed
- Predicted value not including VAT
-
7 020,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.16: LV03AF Acidum levofolinicum
- Status
-
Completed
- Predicted value not including VAT
-
38 280,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.17: L01AA01 Cyclophosphamid
- Status
-
Completed
- Predicted value not including VAT
-
17 350,2000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.18: L01BC02 Fluorouracil
- Status
-
Completed
- Predicted value not including VAT
-
28 424,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.19: L01BA04 Pemetrexed
- Status
-
Completed
- Predicted value not including VAT
-
6 679,2000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.20: L01XA01 Cisplatinum
- Status
-
Completed
- Predicted value not including VAT
-
43 960,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.21: L01XA02 Carboplatin
- Status
-
Completed
- Predicted value not including VAT
-
37 764,2500 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.22: L01XA04 Dacarbazinum
- Status
-
Completed
- Predicted value not including VAT
-
10 509,7000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.23: L01AA06 Ifosfamid
- Status
-
Completed
- Predicted value not including VAT
-
49 988,9000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.24: V03AF01 Mesnum
- Status
-
Completed
- Predicted value not including VAT
-
5 695,0200 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.25: L01DB01 Pegyl. lipoz. Doxorubicin
- Status
-
Completed
- Predicted value not including VAT
-
142 569,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.26: A04AA02 Granisetron
- Status
-
Completed
- Predicted value not including VAT
-
2 127,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.27: A04AA01 Ondansetron
- Status
-
Completed
- Predicted value not including VAT
-
4 840,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.28: L01XC12 Brentuximab vedotin
- Status
-
Completed
- Predicted value not including VAT
-
130 099,8000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.29: L03AA02 Filgrastimum
- Status
-
Completed
- Predicted value not including VAT
-
4 950,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.30: L02BA03 Fulvestrant
- Status
-
Completed
- Predicted value not including VAT
-
249 854,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.31: L01XC08 Panitumumab
- Status
-
Completed
- Predicted value not including VAT
-
67 988,4000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.32: L01XC06 Cetuximab
- Status
-
Completed
- Predicted value not including VAT
-
669 325,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.33: LL01XX44 Aflibercept
- Status
-
Completed
- Predicted value not including VAT
-
59 490,9000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.34: LL01CD01 Paclitaxel viaz. na albumin
- Status
-
Completed
- Predicted value not including VAT
-
215 743,2900 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.35: LL01DB01 doxorubicin lipozomovy
- Status
-
Completed
- Predicted value not including VAT
-
82 390,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.36: LM05BX04 Denosumab
- Status
-
Completed
- Predicted value not including VAT
-
371 756,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.37: LB01AB04 Dalteparín
- Status
-
Completed
- Predicted value not including VAT
-
35 605,8000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.38: LB05AA01 Albumin
- Status
-
Completed
- Predicted value not including VAT
-
34 009,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.39: LV08AB10 Jomeprol
- Status
-
Completed
- Predicted value not including VAT
-
45 187,7000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.40: LV08AB09 Jodixanol
- Status
-
Completed
- Predicted value not including VAT
-
117 751,2000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.41: L01XC03 Trastuzumab
- Status
-
Completed
- Predicted value not including VAT
-
34 730,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.42: L01XC03 Trastuzumab
- Status
-
Completed
- Predicted value not including VAT
-
444 125,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.43: L01XC14 Trastuzumab emtansín
- Status
-
Completed
- Predicted value not including VAT
-
755 666,3400 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.44: LL01XC13 Pertuzumab
- Status
-
Completed
- Predicted value not including VAT
-
648 476,8200 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.45: L01XC18 Pembrolizumab
- Status
-
Completed
- Predicted value not including VAT
-
2 345 712,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.46: LV08AA01 Kyselina amidotrizoova
- Status
-
Completed
- Predicted value not including VAT
-
27 030,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.47: L01XC02 Rituximab
- Status
-
Completed
- Predicted value not including VAT
-
37 328,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.48: L01XC17 Nivolumab
- Status
-
Completed
- Predicted value not including VAT
-
838 748,7000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.49: L01XC21 Ramucirumab
- Status
-
Completed
- Predicted value not including VAT
-
351 623,4000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.50: LB01AB06 Nadroparin
- Status
-
Completed
- Predicted value not including VAT
-
11 330,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.51: LL01CX01 Trabektedín
- Status
-
Completed
- Predicted value not including VAT
-
245 288,9000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.52: L01XX41 Eribulin
- Status
-
Completed
- Predicted value not including VAT
-
238 780,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33652000-5 - Antineoplastic and immunomodulating agents
- Outcome of tender
- Framework Agreement
Časť č.53: B05BB01 chlorid sodný 0,9%
- Status
-
Completed
- Predicted value not including VAT
-
68 103,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.54: B05BB01 chlorid sodný 0,9%
- Status
-
Completed
- Predicted value not including VAT
-
16 482,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.55: B05BB01 chlorid sodný 0,9%
- Status
-
Completed
- Predicted value not including VAT
-
33 422,8500 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.56: B05BA03 glukóza monohydrát 5%
- Status
-
Completed
- Predicted value not including VAT
-
2 036,1600 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.57: B05BA03 glukóza monohydrát 5%
- Status
-
Completed
- Predicted value not including VAT
-
11 605,2300 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.58: B05BA03 glukóza monohydrát 10%
- Status
-
Completed
- Predicted value not including VAT
-
1 633,5300 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.59: B05BB01 Natrii chloridum, Calcii chloridum dihydr., Kalii chloridum
- Status
-
Completed
- Predicted value not including VAT
-
2 367,3000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.60: B05BC01 manitol 10 %
- Status
-
Completed
- Predicted value not including VAT
-
4 448,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement
Časť č.61: LV07AB aqua injectabilis
- Status
-
Completed
- Predicted value not including VAT
-
720,0000 EUR
- Criterion for evaluation of bid
-
Lowest price
- Electronic auction
-
Yes
- Main CPV
-
33692100-8 - Infusion solutions
- Outcome of tender
- Framework Agreement